Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MAPRE2 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | GLB1L2 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | TCP10L | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
mRNA | METTL16 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
mRNA | SYMPK | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | ID2 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | ZNF611 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
mRNA | ANXA7 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | DACH1 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | ZNF275 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |